Literature DB >> 12466339

Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.

K Berneis1, J J Staub, A Gessler, C Meier, J Girard, B Müller.   

Abstract

The metyrapone test is used to test the hypothalamic-pituitary-adrenocortical axis. The present study aims to assess the diagnostic accuracy of combined stimulation of ACTH and compound-S (CMP-S). In addition, we analyzed the safety and practicability of this test as an outpatient procedure. A total of 327 metyrapone tests were analyzed retrospectively in 185 patients (mean age, 50.3 +/- 15.2 yr). One hundred thirteen patients had one test, and 72 patients had between 2 and 6 tests over 1-3 yr. Most patients suffered from pituitary adenomas (60 macroadenomas, 63 microadenomas) or other pituitary lesions (n = 29). Metyrapone (2 g) was given at 2400 h as an outpatient procedure. Blood samples for analysis of ACTH, CMP-S, and cortisol were taken at 0730 h. Stimulation of adrenal CMP-S and cortisol by pituitary ACTH demonstrated a dose-response curve with the shape of half a geometric parabola. CMP-S reached a plateau when ACTH rose above 175 ng/liter [r = 0.661, P < 0.0001 for ACTH <175 ng/liter; r = 0.083, P = not significant (NS) for ACTH >175 ng/liter], cortisol flattened at ACTH levels above 230 ng/liter (r = 0.633; P < 0.0001 for ACTH < 230 ng/liter; P = NS for ACTH >230 ng/liter). Alternatively, the sum of CMP-S plus cortisol also flattened when ACTH rose above 230 ng/liter (r = 0.696; P < 0.0001 for ACTH <230; P = NS for ACTH > 230 ng/liter). Receiver operating curve analysis defining a cut-off for ACTH at 150 ng/liter demonstrated a sensitivity of 47% and 67% at a cut-off level for CMP-S at 200 or 260 nmol/liter, respectively. The respective specificity was 82% and 68% for CMP-S. This compared with a sensitivity of 71% and specificity of 69% if the sum of CMP-S plus cortisol of 450 nmol/liter were used as cut-off. The response curve between CMP-S and ACTH implies a maximally stimulated adrenal cortex at circulating ACTH levels above 175 ng/liter. Single measurement of CMP-S using the cut-off at 200 nmol/liter, as suggested in the literature, yields a poor sensitivity of only 47% compared with ACTH. Despite the relatively high cross-reactivity of CMP-S in the cortisol assay, the sum of CMP-S and cortisol levels with a cut-off value of 450 nmol/liter yields a better diagnostic accuracy compared with CMP-S alone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466339     DOI: 10.1210/jc.2001-011959

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

Review 2.  Diagnosis and treatment of hypopituitarism: an update.

Authors:  M O van Aken; S W J Lamberts
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 3.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 4.  What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock?

Authors:  Rajesh Aneja; Joseph A Carcillo
Journal:  Arch Dis Child       Date:  2006-09-26       Impact factor: 3.791

Review 5.  [Hypophyseal coma].

Authors:  B L Herrmann; K Mann
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

Review 6.  Isolated corticotrophin deficiency.

Authors:  Massimiliano Andrioli; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

7.  The use of bone age for bone mineral density interpretation in a cohort of pediatric brain tumor patients.

Authors:  E Brannon Morris; John Shelso; Matthew P Smeltzer; Nicole A Thomas; E Jane Karimova; Chin-Shang Li; Thomas Merchant; Amar Gajjar; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-09-04

Review 8.  Adrenal insufficiency in patients with decompensated cirrhosis.

Authors:  Apostolos Ka Karagiannis; Theodora Nakouti; Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Hepatol       Date:  2015-05-18

Review 9.  Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis.

Authors:  Zuleyha Karaca; Ashley Grossman; Fahrettin Kelestimur
Journal:  Rev Endocr Metab Disord       Date:  2021-03-26       Impact factor: 6.514

10.  Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Ursula Schild; Erika Süess; Michael Facompre; Florent Baty; Charly Nusbaumer; Martin Brutsche; Beat Müller
Journal:  BMC Pulm Med       Date:  2008-01-26       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.